NWU2015-06-03
|
CLO-Northwestern University
|
Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
NWU2015-06-04
|
CLO-Northwestern University
|
Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
NWU2016-08-02
|
CLO-Northwestern University
|
A Phase I Single-Arm, Multicenter Pilot Study Aimed at Validating Gamma-OHPdG as a Biomarker and Testing the Effects of Polyphenon E® on its Levels in Patients with Cirrhosis
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
NWU2017-09-01
|
CLO-Northwestern University
|
Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
NWU21-08-01
|
CLO-Northwestern University
|
Phase II Trial of Oral Iloprost for the Precision Chemoprevention of Lung Cancer
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
PACCT-1
|
ECOG
|
Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
PBTC-049
|
PBTC
|
A Phase I study of Savolitinib in Recurrent, Progressive or Refractory Medulloblastoma, High-Grade Glioma, Diffuse Intrinsic Pontine Glioma and CNS tumors harboring MET aberrations
|
Pediatric CIRB
|
Available to Open
|
|
PBTC-051
|
PBTC
|
Phase I Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005M in Pediatric Subjects with Recurrent/Refractory Brain Tumors and Newly Diagnosed Brain Stem Glioma
|
Pediatric CIRB
|
Available to Open
|
|
PBTC-053
|
PBTC
|
A Pediatric Brain Tumor Consortium Phase I/II and Surgical Study of CX-4945 in Patients with Recurrent SHH Medulloblastoma
|
Pediatric CIRB
|
Available to Open
|
|
PBTC-055
|
PBTC
|
Phase I/II trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ) for BRAF V600E-mutant or Trametinib and HCQ for BRAF fusion/duplication positive or NF1-associated recurrent or progressive gliomas in children and young adults
|
Pediatric CIRB
|
Available to Open
|
|